Trial intelligence / Profile preview

Adacel vs Daptacel as 5th Dose Booster in Children 4-6 Years

NCT00467519Phase 3Completed

Sponsor
Sanofi
Start
Apr 2007
Primary completion
Nov 2009
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 3 trial of acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Sanofi. Started Apr 2007; status: completed.

02

Drugs

acellular pertussis vaccine
03

Conditions

Tetanusdiphtheriapertussis

Beyond the preview

Go deeper on NCT00467519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00467519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call